• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Optimal timing of preoperative intravitreal anti-VEGF injection for proliferative diabetic retinopathy patients

    2022-10-24 09:11:30YueXuChiXieYanFangYanYuCuiQiu
    International Journal of Ophthalmology 2022年10期

    Yue Xu, Chi Xie, Yan Fang, Yan Yu, Cui Qiu

    1Department of Ophthalmology, the First Affiliated Hospital of Anhui University of Science & Technology, Huainan 232001,Anhui Province, China

    2Institute of Ophthalmology, Anhui University of Science &Technology, Huainan 232001, Anhui Province, China

    Abstract

    ● KEYWORDS: preoperative timing; intravitreal anti-VEGF injection; angio-fibrosis switch; proliferative diabetic retinopathy

    INTRODUCTION

    Proliferative diabetic retinopathy (PDR) is a serious ocular microvascular complication of diabetes characterized by pathological neovascularization with or without fibrovascular proliferation[1-3]. Disease progression leads to contraction of proliferative fibrovascular membranes (FVMs) that can cause vitreous hemorrhage (VH) and tractional retinal detachment(TRD) eventually leading to blindness. Many studies have confirmed that vascular endothelial growth factor (VEGF)is an important inducing factor involved in this pathological process, and its levels are closely related to the severity of PDR[4-7]. Therefore, in the past 10y, VEGF inhibitors (anti-VEGFs) have been widely used as adjunct treatment for PDR patients. At present, intravitreal anti-VEGF injections (IVI) are performed as an important ancillary treatment in combination with pars plana vitrectomy (PPV) in PDR patients[8-9].

    It is undeniable that the clinical results of PDR patients treated with preoperative IVI combined with PPV are significantly better than those of patients treated with PPV alone. Numerous retrospective studies have confirmed that preoperative IVI can promote regression of neovascularization, minimize intraoperative bleeding during segmentation of FVMs, shorten operation time, and reduce the occurrence of postoperative VH, as well as decrease the likelihood of other intraoperative and postoperative-associated complications[10-13]. Moreover,the visual prognosis of patients treated with preoperative IVI combined with PPV was better than that of patients treated with PPV alone.

    Although the emergence of anti-VEGF drugs marks a great progress in the treatment of PDR, an increasing number of studies have provided evidence that IVI is effective in some PDR patients, while others develop progressive severity of fibrosis, especially when the interval between IVI and PPV is long[14-17].Liet al[18]showed that the timing of anti-VEGF therapy played an important role in the development of fibrosis, supporting the idea that the timing of preoperative IVI can be an important factor in determining whether anti-VEGF treatment will be a beneficial or detrimental adjunct to PPV.

    At present, the mechanism of fibrosis aggravation after IVI remains unclear. Klaassenet al[19]proposed that this phenomenon was related to the angio-fibrotic switch. In other words, at some point there was a transition from angiogenesis inhibition to fibrosis promotion. Therefore, we theorize that IVI not only blocks VEGF but also causes changes in the concentrations of other cytokines in PDR patients.

    The aim of the present study was to analyze the concentrations of various cytokines in the vitreous fluid and to correlate this with the severity of fibrosis in PDR patients based on different lengths of time between IVI and PPV, and to elucidate the specific molecular mechanism of the angio-fibrosis switch, so as to provide a reference for retinal surgeons to the optimal timing for anti-VEGF treatment.

    SUBJECTS AND METHODS

    Ethical ApprovalThe study was conducted in accordance with the principles of the Declaration of Helsinki and was approved by the institutional review board and Ethical Committee of the First Affiliated Hospital of Anhui University of Science & Technology. All patients voluntarily signed informed consent after having been provided with a detailed description of the treatment.

    PatientsWe conducted a prospective case-control study of 31 eyes of 31 PDR patients (PDR group) and 21 eyes of 21 non-diabetic controls including patients with macular hole or rhegmatogenous retinal detachment (control group) who underwent 23-G PPV at the Ophthalmology Department of the First Affiliated Hospital of Anhui University of Science &Technology in Huainan, China, between January 2019 and July 2020.

    The surgical indications of the PDR group included persistent VH and TRD with proliferative FVMs. The exclusion criteria included the following: 1) a history of previous ocular surgery (e.g., phacoemulsification, trabeculectomy),2) previous treatment with anti-VEGF therapy or pan-retinal photocoagulation within 6mo, 3) a history of topical antiinflammatory drops like as nepafenac, 4) presence of other retinal neovascular diseases (e.g., retinal vein occlusion), 5)presence of other ocular diseases that seriously affect visual function (e.g., keratitis, optic neuritis, uveitis, high myopia,and amblyopia).

    Eligible PDR patients were divided into two groups, one group was pre-treated with IVI prior to PPV (n=26; IVI PDR group)and the other group was not pretreated with IVI (n=5; no IVI group). The IVI PDR group was further subdivided into three groups based on the timing of pretreatment: 1) PDR patients who underwent PPV 3d after IVI (n=9; 3-day group); 2)PDR patients who underwent PPV 5d after IVI (n=10; 5-day group); 3) PDR patients who underwent PPV ≥7d after IVI(n=7; ≥7-day group). Two kinds of anti-VEGF drugs were used in IVI PDR group, of which 3, 6, and 3 eyes were pretreated with intravitreal conbercept injections respectively in 3-day group, 5-day group and ≥7-day group and 6, 4, 4 eyes were pre-treated with ranibizumab respectively. There was no statistical difference in the types of anti-VEGF drugs among subgroups (χ2=1.397,P=0.497).

    ExaminationsAll patients underwent comprehensive preoperative ophthalmic and medical examinations. Eye examinations included slit-lamp biomicroscopy, intraocular pressure (IOP) measurement, ocular B-scan ultrasonography,ultra-wide-angle fundus photography, and spectral domain optical coherence tomography (SD-OCT). Fundus fluorescein angiography (FFA) was used to assess macular perfusion status if necessary.

    The degree of vitreoretinal fibrosis in PDR patients was graded according to the classification reported byKuiperet al[20]as follows:grade 0, no fibrosis; grade 1, few pre-retinal membranes; grade 2, white preretinal fibrotic membranes with limited extension into the vitreous; grade 3, abundant white membranes reaching into the vitreous body.

    Sample CollectionUndiluted vitreous fluid samples (0.5-1 mL) were obtained before PPV without switching on the infusion fluid. The samples were centrifuged at 3000 g for 10min at 4℃ and the supernatant was immediately transferred to a different sterile Eppendorf?tube. All preliminary centrifuged samples were stored in the refrigerator at -80℃ until further analysis.

    Measurement of CytokinesviaLuminex TechnologyA human premixed multi-analyte kit (R&D Systems, Austin, TX,USA) was used to measure the concentrations of cytokines in vitreous fluid samples. The cytokines measured included VEGF, basic fibroblast growth factor (bFGF), periostin (PN),interleukin (IL)-6, IL-8, and tumor necrosis factor (TNF)-α.The preliminary centrifuged samples were diluted 2-fold with calibrator diluent RD6-52. First, 50 μL of the diluted sample and microparticle cocktail were added to each well of the microplate and incubated for 2h at room temperature on a horizontal orbital microplate shaker (0.12s orbit) set at 800±50 rpm. Afterwards, the microplate was washed by removing the liquid from each well, filling the wells with 100 μL wash buffer, and removing the liquid again; this procedure was performed three times. Next, 50 μL of diluted biotin-antibody cocktail were added to each well and incubated for 1h at room temperature on the shaker set at 800 rpm.Subsequently, the wash was repeated as described above,followed by the addition of 50 μL of diluted Streptavidin-PE to each well and incubation for 30min at room temperature on the shaker set at 800 rpm. Following this, the wash was repeated for the third time and 100 μL of wash buffer were added to each well and incubated for 2min at room temperature on the shaker set at 800 rpm. Finally, the concentration values were obtained from the mean fluorescent intensity (MFI) by using Luminex 200? System (xPONENT Software). Standard curves were generated from the reference cytokine gradient concentrations. The concentrations of cytokines in vitreous fluid samples were calculated from the standard curves.

    Statistical AnalysisSPSS 22.0 software (SPSS, Inc., Chicago,IL, USA) was used for statistical analysis. The Shapiro-Wilk test was performed to examine whether the data were distributed normally. Data are presented as the mean±standard deviation (SD) or as median and range. Statistical significances of cytokine concentration among the groups were determined using the Kruskal-WallisHtest with Bonferroni post hoc test,while differences between two groups were estimated using a non-parametric Mann-WhitneyUtest. Aχ2or Fisher exact test was conducted to compare noncontinuous variables.The spearman rank correlation test was used to analyze the correlation between the degree of vitreoretinal fibrosis and the concentration of cytokines. Based on the results of univariate analysis, the degree of vitreoretinal fibrosis was taken as the dependent variable, and the factors ofP<0.05 were included in the multivariate regression model for multivariate ordered logistic regression analysis. AP-value <0.05 was considered statistically significant.

    RESULTS

    Patient CharacteristicsCharacteristics of the 52 patients studied are shown in Table 1. Statistical analysis demonstrated that there was no significant difference in sex (P=1.000) and age (P=0.178) among the IVI PDR group, no IVI PDR group,and the control group. There was also no significant difference in hemoglobin A1c (HbA1c) and indication for PPV between the pretreated and non-pretreated PDR groups (P=0.755, 0.525,1.000, and 1.000, respectively; allP>0.05; Table 1).

    Vitreous Fluid Cytokine ConcentrationsThe cytokine concentration values for the IVI PDR group, no IVI PDR group, and the control group are shown in Table 2. The concentrations of VEGF, bFGF, PN, and IL-6 were all significantly higher in the no IVI group than in the control group (Z=-3.420, -2.279, -2.950, and -3.027, respectively; allP<0.05), while no significant differences were observed in IL-8 and TNF-α between the two groups (bothP>0.05). In addition,the IVI group had a significantly lower concentration of VEGF(Z=-3.491,P<0.05) and a significantly higher concentration of IL-8 (Z=-2.363,P<0.05) than the no IVI group. While there were no significant differences in bFGF, PN, IL-6, and TNF- α concentrations between the two groups (allP>0.05).

    There were significant differences in VEGF, bFGF, PN, IL-6,IL-8, and TNF-α concentrations in the vitreous fluid among the five groups (F=42.105, 36.653, 33.396, 28.517, 26.554, and 18.326, respectively; allP<0.01; Figure 1).

    We further compared the concentrations of cytokines among the 3-day group, 5-day group, and ≥7-day group and discovered that the differences in VEGF, bFGF, PN, IL-6, and IL-8 concentrations were statistically significant (F=13.077,16.524, 10.440, 7.748, and 8.960, respectively; allP<0.05).There was no significant difference among the 3 subgroups in TNF-α concentration (F=2.978,P=0.226).

    Vitreous fluid samples in the 5-day group had the lowest concentration of VEGF, and this was statistically significant compared with the 3-day group (P=0.002) and the ≥7-day group (P=0.024). However, there was no significant difference in the concentrations of vitreous VEGF between the 3-day group and ≥7-day group (P>0.05).

    In addition, vitreous fluid samples in the ≥7-day group had the highest concentrations of bFGF and PN, and this was statistically significant compared with the 3-day group(P=0.000,P=0.008, respectively) and the 5-day group(P=0.012,P=0.020, respectively). No significant differences were found in the concentrations of vitreous bFGF and PN between the 3-day group and 5-day group (bothP>0.05).The concentrations of IL-6 and IL-8 in the ≥7-day group were both significantly higher than in the 3-day group (P=0.019,P=0.014, respectively), whereas no significant differences in IL-6 and IL-8 concentrations were observed between the 5-day group and ≥7-day group (bothP>0.05), as well as between the 3-day group and 5-day group (bothP>0.05; Figure 2).

    Figure 1 Concentrations of cytokines in vitreous fluid of patients in each group VEGF: Vascular endothelial growth factor; IVI: Intravitreal anti-VEGF injections; bFGF: Basic fibroblast growth factor; IL: Interleukin; TNF: Tumor necrosis factor.

    Table 1 Patient characteristics

    Table 2 Concentrations of cytokines in vitreous fluid of patients in each group median (range)

    Figure 2 Concentration of cytokines in vitreous fluid of patients pre-treated with IVI at different time periods prior to PPV VEGF:Vascular endothelial growth factor; IVI: Intravitreal anti-VEGF injections; bFGF: Basic fibroblast growth factor; IL: Interleukin; TNF: Tumor necrosis factor. aP<0.05 by Kruskal-Wallis H test.

    Figure 3 Correlation between the degree of vitreoretinal fibrosis and the concentration of cytokines in patients after intravitreal injection of anti-VEGF drugs VEGF: Vascular endothelial growth factor; bFGF: Basic fibroblast growth factor; IL: Interleukin.

    Correlation of Vitreous Fluid Cytokine Concentrations and Degree of Vitreoretinal Fibrosis There was no difference in the degree of vitreoretinal fibrosis between the no IVI PDR group and IVI PDR group (χ2=1.143,P=0.911). When comparing the IVI PDR subgroups in terms of vitreoretinal fibrosis, a statistically significant difference was found(Z=8.988,P=0.011). No patient in the 3-day group exhibited vitreoretinal fibrosis of grade 3; on the contrary, in the ≥7-day group, vitreoretinal fibrosis of grade 3 occurred in 57% (4/7)of cases. Overall, the degree of vitreoretinal fibrosis increased significantly after IVI in the ≥7-day group compared to the 3-day group (P=0.015) and the 5-day group (P=0.039; Table 3).For the primary outcome, the correlation between the degree of vitreoretinal fibrosis and the concentration of cytokines was analyzed by Spearman rank correlation test. In the IVI group,our analysis revealed that the degree of vitreoretinal fibrosis and the bFGF, PN, IL-6, and IL-8 concentrations correlated significantly (allP<0.05), with a Spearman’s value of 0.879,0.608, 0.488, and 0.529, respectively. On the contrary, the degree of vitreoretinal fibrosis did not correlate with the intravitreal concentration of VEGF (P=0.373) and TNF- α(P=0.587; Figure 3).Univariate ordinal regression analysis to determine predictors of vitreoretinal fibrosis showed that bFGF, PN, IL-6, and IL-8 concentrations had similar associations with the degree of vitreoretinal fibrosis in the IVI PDR groups (allP<0.05).In a multivariate model with bFGF, PN, IL-6, and IL-8 concentrations as predictors of vitreoretinal fibrosis, bFGF was an independent risk factor for the progression of fibrosis in PDR patients pre-treated with IVI (Table 4).

    Table 3 Comparison of the degree of fibrosis in patients pre-treated with IVI at different time periods prior to PPV

    Table 4 Ordered logistic regression analysis of vitreoretinal fibrosis

    DISCUSSION

    The development of diabetic retinopathy (DR) into advanced proliferative lesions involves a series of complicated pathological changes. From the macroscopic point of view, it is mainly the pathological changes of retinal micro-vessels,while from the microscopic, molecular, biological level, the increase or decrease of different kinds of cytokines in the eye and changes in the retinal immune microenvironment mediated by these cytokines accelerate the pathological progression of PDR. Changes in VEGF concentrations are the key event, mainly because VEGF is an important factor in retinal vascular leakage and pathological neovascularization.In this pilot study, significantly higher concentrations of VEGF were detected in the vitreous samples of PDR patients who were not pretreated with IVI compared to non-diabetic controls. In the last 10y, targeted inhibition of VEGF has been widely applied clinically as adjuvant therapy for PDR,especially as preoperative IVI prior to PPV[8-9].

    Consistent with previous reports, we found that concentrations of VEGF were significantly lower in PDR patients pretreated with IVI. As VEGF inhibitors, anti-VEGF drugs prevent VEGF from binding to VEGF receptors such as vascular endothelial growth factor receptor-2 (VEGFR-2), thereby inhibiting endothelial cell proliferation and reducing vascular leakage, thus eliminating fragile neovascularization or inhibiting its formation[21-22]. A large number of studies have confirmed that preoperative IVI combined with PPV in the treatment of PDR can not only reduce intraoperative and postoperative complications, but also improve the visual prognosis of patients[11-13].

    An important issue in combination therapy is the interval between PPV and IVI pretreatment. From the perspective of VEGF, it seems that the longer the interval time, the lower the VEGF concentration and the greater the advantage of combination therapy. Our study further compared the concentrations of VEGF in the vitreous at different time after anti-VEGF therapy, and found that VEGF concentrations decreased dramatically at 3, 5 and 7d after injection, and reached the lowest concentrations in patients who underwent PPV 5d after IVI. At present, reports on the changes in intraocular VEGF concentrations after IVI at different intervals are not consistent. Fenget al[23]proved that bevacizumab could reduce the concentration of VEGF in aqueous fluid of PDR patients and remaine low for 14d. Maet al[24]reported that VEGF concentrations in vitreous fluid of PDR patients decreased significantly after intravitreal bevacizumab injection, and this low concentration remained for 4.4±2.2 to 34.8±33.7d, with the lowest value appearing within one week after injection. Judging from the above, there is no doubt that preoperative IVI can block intraocular VEGF levels, but this inhibitory effect is time-limited, so if clinicians want to improve the success rate and postoperative outcome of PPV in PDR patients, the timing of intravitreal injection of anti-VEGF before PPV should be chosen at the peak of drug action.

    In the present study, we observed another important phenomenon: vitreoretinal fibrosis can develop or progress following IVI treatment, especially with a long interval between IVI and PPV. We compared the degree of vitreoretinal fibrosis after IVI at different times and found that grade 3 was dominant in the ≥7-day group, accounting for 57%, and the degree of vitreoretinal fibrosis was more serious than that in the 3-day group and 5-day group. El-Sabaghet al[25]showed that the longer the interval between intravitreal bevacizumab injection and PPV, the higher the degree of vitreoretinal fibrosis in eyes with PDR, while neovascularization in FVMs decreased significantly. It can be seen that vitreoretinal fibrosis will develop or progress with longer time intervals between IVI pretreatment and PPV; therefore, it is not advisable prolong the interval in clinic. Some prior studies have suggested that the above complications may be closely related to the angiofibrotic switch[19-20,26], but the mechanism of this switch has not been elucidated.

    Kuiperet al[20]discovered that the balance between connective tissue growth factor (CTGF) and VEGF determined the angiofibrotic switch, and disruption of this balance could promote the transformation from angiogenesis to fibrosis in PDR patients. Combined with our study, one possibility is that preoperative IVI not only decreased VEGF but also caused changes in the levels of other cytokines in PDR accordingly,which triggered the angio-fibrotic switch and disrupted the angio-fibrotic balance.

    Our study further analyzed the changes in concentrations of other cytokines in the vitreous fluid of PDR patients after administration of anti-VEGF drugs at different times before PPV. We observed that intraocular concentrations of bFGF and periostin were highest in the ≥7-day group and were positively correlated with the degree of vitreoretinal fibrosis. In addition,the concentrations of IL-6 and IL-8 inflammatory cytokines in the ≥7-day group were significantly higher than those in the 3-day group. The role of bFGF and PN as pro-fibrotic cytokines is well-established in various diseases and recently in retinopathy as well[27-31]. IL-6 and IL-8 are members of the IL family involved in inflammation[32-33]. The changes in the above cytokine concentrations in this study can be related to a sharp and continuous decline in VEGF levels, which causes a compensatory increase of pro-fibrosis and inflammatory cytokine concentrations. When the level of these cytokines reaches a threshold value, especially pro-fibrosis factors, the angio-fibrotic switch will be triggered, which can further upregulate the expression of pro-fibrosis cytokines. In addition,with the progression of vitreoretinal fibrosis, retinal hypoxia is aggravated, which leads to a certain degree of inflammation.Fibrosis and inflammation interact with each other, forming a vicious cycle. Therefore, the optimal timing of preoperative IVI treatment for PDR patients is when anti-VEGF drugs can minimize intraocular VEGF concentrations and do not trigger the angio-fibrotic switch. On the basis of our research, it is suggested that PPV should be performed 5d after IVI.

    In addition, it is worth mentioning that multivariate ordered logistic regression analysis showed bFGF was an independent risk factor for the progression of vitreoretinal fibrosis in active PDR patients after IVI. This suggests that bFGF may be a new target for anti-fibrosis therapy, anti-bFGF combined with anti-VEGF drugs can be considered to assist PPV in the treatment of PDR in the future.

    Our study has some limitations. First, our findings should be considered preliminary. However, our previous clinical study found that the degree of vitreoretinal fibrosis could be aggravated with prolonged interval between IVI and PPV.Such favorable outcomes require larger-scale clinical trials to be proven. Second, this study elucidated the mechanism of the“angio-fibrotic switch” only by detecting the concentration of cytokines in the vitreous fluid. Further studies with a larger sample size and immunohistochemical experiments of FVMs are needed to co-validate the data.

    In summary, in PDR patients, the vitreous concentrations of a variety of cytokines will change after pretreatment with IVI before PPV. Prolonged blocking of VEGF cytokine may trigger the “angio-fibrotic switch”. We suggest that PPV be performed on the fifth day after the administration of anti-VEGF drugs in PDR patients because VEGF concentrations in vitreous fluid reached the lowest level, and concentrations of bFGF and PN have not increased significantly. Meanwhile,the degree of vitreoretinal fibrosis can significantly increase in patients with a pretreatment interval ≥7d prior to PPV, which is mainly related to the significantly increased concentrations of bFGF, PN, IL-6, and IL-8 in the vitreous fluid. bFGF is an independent risk factor for fibrosis progression and is expected to become a new target for anti-fibrosis therapy.

    ACKNOWLEDGEMENTS

    Foundations:Supported by the Guiding Science and Technology Plan Project of Huainan City (No.2020044);Construction Project of Key Medical and Health of Anhui Province in 2021.

    Conflicts of Interest:Xu Y,None;Xie C,None;Fang Y,None;Yu Y,None;Qiu C,None.

    99热这里只有是精品50| 亚洲久久久国产精品| 老司机影院毛片| 日本与韩国留学比较| 日韩三级伦理在线观看| 日日摸夜夜添夜夜爱| 久久精品夜色国产| 亚洲第一av免费看| 男人添女人高潮全过程视频| 18+在线观看网站| 亚洲图色成人| 婷婷色av中文字幕| 99久久人妻综合| 精品久久久噜噜| 国产午夜精品一二区理论片| 亚洲国产精品999| 波野结衣二区三区在线| 亚洲欧美一区二区三区黑人 | 亚洲精品一二三| 大香蕉久久网| 久久人妻熟女aⅴ| 蜜臀久久99精品久久宅男| 亚洲精品,欧美精品| freevideosex欧美| 亚洲av国产av综合av卡| 免费高清在线观看视频在线观看| 欧美亚洲 丝袜 人妻 在线| 国产免费一级a男人的天堂| 1000部很黄的大片| 夜夜看夜夜爽夜夜摸| 国产白丝娇喘喷水9色精品| 欧美区成人在线视频| 亚洲成人av在线免费| 人人妻人人澡人人爽人人夜夜| 波野结衣二区三区在线| 日本-黄色视频高清免费观看| 成人亚洲欧美一区二区av| 色综合色国产| 午夜福利在线在线| 亚洲精品日韩av片在线观看| 国产精品久久久久久久电影| 久久这里有精品视频免费| 尤物成人国产欧美一区二区三区| 99久久人妻综合| 成人美女网站在线观看视频| 久久毛片免费看一区二区三区| 国产精品一区二区在线观看99| 大话2 男鬼变身卡| 亚洲精品日韩在线中文字幕| 国产极品天堂在线| 国产免费一级a男人的天堂| 内射极品少妇av片p| 性高湖久久久久久久久免费观看| 熟妇人妻不卡中文字幕| 精品一品国产午夜福利视频| 看免费成人av毛片| 黑丝袜美女国产一区| 欧美精品人与动牲交sv欧美| 亚洲精品一区蜜桃| 高清av免费在线| 亚洲国产欧美人成| 亚洲精品国产色婷婷电影| 丰满少妇做爰视频| 97热精品久久久久久| 免费大片18禁| 国产精品女同一区二区软件| 国产视频首页在线观看| 久久人人爽av亚洲精品天堂 | 涩涩av久久男人的天堂| 熟妇人妻不卡中文字幕| 小蜜桃在线观看免费完整版高清| 午夜福利高清视频| 久久久精品94久久精品| 欧美丝袜亚洲另类| 一个人看视频在线观看www免费| 日本与韩国留学比较| 中国国产av一级| 韩国高清视频一区二区三区| a级一级毛片免费在线观看| av在线蜜桃| 在线观看三级黄色| 久久久久网色| 久久毛片免费看一区二区三区| 亚洲精品日韩在线中文字幕| 精品少妇久久久久久888优播| 亚洲精品成人av观看孕妇| 少妇精品久久久久久久| 春色校园在线视频观看| 色视频www国产| 欧美老熟妇乱子伦牲交| 亚洲精品一二三| 美女福利国产在线 | 国产成人精品一,二区| 亚洲欧美日韩另类电影网站 | 国产淫语在线视频| 在线精品无人区一区二区三 | 我要看黄色一级片免费的| 久久精品久久久久久久性| 观看免费一级毛片| 日韩一区二区视频免费看| 亚洲av成人精品一二三区| 高清av免费在线| 青春草亚洲视频在线观看| 日本爱情动作片www.在线观看| 高清不卡的av网站| 亚洲国产精品成人久久小说| 国产深夜福利视频在线观看| 中文资源天堂在线| av网站免费在线观看视频| 人妻夜夜爽99麻豆av| 熟女电影av网| 日本色播在线视频| 综合色丁香网| 狂野欧美白嫩少妇大欣赏| 国产精品久久久久久久久免| 中文资源天堂在线| 99视频精品全部免费 在线| 日韩不卡一区二区三区视频在线| 又粗又硬又长又爽又黄的视频| 久久精品久久精品一区二区三区| 国产片特级美女逼逼视频| 亚洲成人一二三区av| 一级毛片aaaaaa免费看小| av福利片在线观看| 亚洲精品,欧美精品| 国产伦精品一区二区三区视频9| 激情五月婷婷亚洲| 国产黄片视频在线免费观看| 香蕉精品网在线| 尤物成人国产欧美一区二区三区| 麻豆成人av视频| 人人妻人人澡人人爽人人夜夜| 国产一区二区三区av在线| 久久久国产一区二区| 天堂8中文在线网| 大香蕉97超碰在线| 亚洲精品国产av蜜桃| 国产精品国产av在线观看| 欧美日韩视频精品一区| 日韩制服骚丝袜av| 成人漫画全彩无遮挡| 国产亚洲一区二区精品| 一个人免费看片子| 久久精品国产亚洲av涩爱| .国产精品久久| 精品久久久久久久久亚洲| 免费av中文字幕在线| 一区二区三区乱码不卡18| 蜜桃亚洲精品一区二区三区| 干丝袜人妻中文字幕| 国产黄片视频在线免费观看| 国产精品久久久久久精品电影小说 | 国产真实伦视频高清在线观看| 亚洲激情五月婷婷啪啪| 欧美日韩综合久久久久久| 三级国产精品欧美在线观看| 三级国产精品欧美在线观看| 久久热精品热| 亚洲av成人精品一二三区| 亚洲欧洲国产日韩| 我要看日韩黄色一级片| 大片免费播放器 马上看| 一个人免费看片子| 亚洲一区二区三区欧美精品| 好男人视频免费观看在线| 亚洲人成网站高清观看| 国产精品偷伦视频观看了| 少妇裸体淫交视频免费看高清| 成年av动漫网址| 夫妻性生交免费视频一级片| 国产亚洲午夜精品一区二区久久| 嘟嘟电影网在线观看| av天堂中文字幕网| 中文精品一卡2卡3卡4更新| 麻豆乱淫一区二区| 国产av精品麻豆| 国产男女内射视频| 亚洲成人一二三区av| 大陆偷拍与自拍| 亚洲欧洲日产国产| 久久久久久久国产电影| 男的添女的下面高潮视频| 观看美女的网站| 内地一区二区视频在线| 中文字幕av成人在线电影| av国产精品久久久久影院| 新久久久久国产一级毛片| 国产高潮美女av| 在线观看美女被高潮喷水网站| 国产一区有黄有色的免费视频| 熟女电影av网| 嫩草影院新地址| 国产日韩欧美亚洲二区| 国产黄频视频在线观看| 一区二区三区免费毛片| 成人午夜精彩视频在线观看| 日日撸夜夜添| 久久精品久久久久久久性| 黄色日韩在线| 国产男女内射视频| 伊人久久国产一区二区| 国产亚洲5aaaaa淫片| 毛片一级片免费看久久久久| 国产伦精品一区二区三区四那| 国产一区二区三区av在线| 一本久久精品| 国产欧美亚洲国产| 欧美国产精品一级二级三级 | 在线精品无人区一区二区三 | 日韩成人伦理影院| 亚洲av福利一区| 日本黄色片子视频| 大话2 男鬼变身卡| 亚洲aⅴ乱码一区二区在线播放| 老师上课跳d突然被开到最大视频| 交换朋友夫妻互换小说| 国产成人a∨麻豆精品| 黄色欧美视频在线观看| 看非洲黑人一级黄片| 国产片特级美女逼逼视频| 亚洲最大成人中文| 国产精品免费大片| 国产欧美日韩一区二区三区在线 | 亚洲av二区三区四区| 国产精品三级大全| 国产久久久一区二区三区| 欧美精品人与动牲交sv欧美| 欧美成人一区二区免费高清观看| 久久av网站| 高清日韩中文字幕在线| 国产亚洲一区二区精品| 人妻夜夜爽99麻豆av| 国产黄片视频在线免费观看| 亚洲av成人精品一区久久| 欧美亚洲 丝袜 人妻 在线| 97热精品久久久久久| 夜夜爽夜夜爽视频| 中文字幕av成人在线电影| 久久人妻熟女aⅴ| 赤兔流量卡办理| 日本免费在线观看一区| 在线观看一区二区三区| 一级二级三级毛片免费看| 综合色丁香网| 日本黄色日本黄色录像| 亚洲无线观看免费| 亚洲精品视频女| 久久久久久九九精品二区国产| 蜜臀久久99精品久久宅男| 精华霜和精华液先用哪个| 日韩精品有码人妻一区| 久久久久久伊人网av| 五月玫瑰六月丁香| 狂野欧美激情性xxxx在线观看| 中国国产av一级| 天天躁日日操中文字幕| av不卡在线播放| 黄色视频在线播放观看不卡| 青春草国产在线视频| 欧美高清性xxxxhd video| 国产色爽女视频免费观看| 亚洲精华国产精华液的使用体验| 女人久久www免费人成看片| 婷婷色麻豆天堂久久| 人人妻人人添人人爽欧美一区卜 | 直男gayav资源| 免费少妇av软件| 成人午夜精彩视频在线观看| 精品一品国产午夜福利视频| 亚洲av成人精品一区久久| 日本欧美视频一区| 看免费成人av毛片| 日本黄色日本黄色录像| 日韩,欧美,国产一区二区三区| 性高湖久久久久久久久免费观看| 亚洲电影在线观看av| 在线观看av片永久免费下载| 精华霜和精华液先用哪个| 少妇被粗大猛烈的视频| 成人国产av品久久久| 国产欧美另类精品又又久久亚洲欧美| 国产91av在线免费观看| 国产精品偷伦视频观看了| 久久久久精品性色| 国产精品一区二区性色av| 日日摸夜夜添夜夜爱| 亚洲无线观看免费| 一级二级三级毛片免费看| h视频一区二区三区| 国产精品av视频在线免费观看| 美女高潮的动态| 国产乱人视频| 夜夜骑夜夜射夜夜干| 岛国毛片在线播放| 嫩草影院新地址| 欧美老熟妇乱子伦牲交| 我要看日韩黄色一级片| 欧美老熟妇乱子伦牲交| 我要看日韩黄色一级片| 国产精品不卡视频一区二区| 中国国产av一级| 精品一品国产午夜福利视频| 九色成人免费人妻av| 国产乱人偷精品视频| 免费观看a级毛片全部| 午夜激情福利司机影院| 久久精品人妻少妇| 欧美精品亚洲一区二区| 成年美女黄网站色视频大全免费 | 午夜免费鲁丝| 欧美老熟妇乱子伦牲交| 成人18禁高潮啪啪吃奶动态图 | 99热全是精品| 亚洲精品久久久久久婷婷小说| 亚洲国产色片| 欧美三级亚洲精品| 插阴视频在线观看视频| 久久国产精品大桥未久av | 欧美成人精品欧美一级黄| 日韩人妻高清精品专区| 成年人午夜在线观看视频| 欧美区成人在线视频| 亚洲aⅴ乱码一区二区在线播放| 男女下面进入的视频免费午夜| 久久久久国产精品人妻一区二区| 两个人的视频大全免费| 欧美成人一区二区免费高清观看| 伦理电影大哥的女人| 综合色丁香网| 欧美激情国产日韩精品一区| 国产精品精品国产色婷婷| 久久久久久久亚洲中文字幕| 七月丁香在线播放| 乱码一卡2卡4卡精品| 哪个播放器可以免费观看大片| 久久久久国产精品人妻一区二区| 日韩一本色道免费dvd| 国产老妇伦熟女老妇高清| 国产av码专区亚洲av| 91精品国产国语对白视频| 久久久久久久久久成人| 天堂8中文在线网| 国产精品人妻久久久久久| 日本猛色少妇xxxxx猛交久久| 精品亚洲成a人片在线观看 | 国产精品人妻久久久久久| 亚洲av福利一区| 久久久a久久爽久久v久久| 亚洲怡红院男人天堂| 欧美极品一区二区三区四区| 国产黄色免费在线视频| 欧美xxxx性猛交bbbb| 日本-黄色视频高清免费观看| 97热精品久久久久久| 三级经典国产精品| 亚洲婷婷狠狠爱综合网| 色网站视频免费| 一二三四中文在线观看免费高清| 亚洲国产日韩一区二区| 亚洲欧美日韩卡通动漫| www.av在线官网国产| 免费观看性生交大片5| 久久精品国产亚洲av涩爱| 观看美女的网站| 欧美+日韩+精品| 在线观看国产h片| 亚洲精华国产精华液的使用体验| 我要看日韩黄色一级片| 国产探花极品一区二区| 一区二区三区四区激情视频| 亚洲中文av在线| 午夜福利视频精品| 插逼视频在线观看| 欧美日韩国产mv在线观看视频 | 少妇人妻精品综合一区二区| 久久久亚洲精品成人影院| 欧美xxxx性猛交bbbb| 男人舔奶头视频| 亚洲欧美中文字幕日韩二区| 国产永久视频网站| 久久久久性生活片| 日本午夜av视频| 中文字幕制服av| 成人国产麻豆网| 亚洲精品一区蜜桃| 一区二区av电影网| 国产亚洲av片在线观看秒播厂| av免费在线看不卡| 男人添女人高潮全过程视频| 亚洲国产欧美人成| 欧美高清成人免费视频www| 黑人猛操日本美女一级片| 国产又色又爽无遮挡免| 久久人人爽av亚洲精品天堂 | 免费观看的影片在线观看| 夜夜看夜夜爽夜夜摸| 男人和女人高潮做爰伦理| 91久久精品电影网| 久久99热6这里只有精品| 亚洲精品,欧美精品| 超碰97精品在线观看| av免费观看日本| 久久久久久人妻| 色婷婷av一区二区三区视频| 一级爰片在线观看| 亚洲国产欧美人成| 久久久久久久久久成人| 天天躁日日操中文字幕| 在线天堂最新版资源| 老司机影院成人| 久久精品人妻少妇| 嘟嘟电影网在线观看| 男女下面进入的视频免费午夜| 老熟女久久久| 欧美精品国产亚洲| 国产精品不卡视频一区二区| 免费观看无遮挡的男女| 肉色欧美久久久久久久蜜桃| 国产黄色视频一区二区在线观看| 免费人妻精品一区二区三区视频| 欧美 日韩 精品 国产| 99热国产这里只有精品6| 99热这里只有精品一区| 日韩中文字幕视频在线看片 | 国产黄片视频在线免费观看| 久久女婷五月综合色啪小说| 色婷婷久久久亚洲欧美| 免费高清在线观看视频在线观看| 国产欧美日韩一区二区三区在线 | 精品国产乱码久久久久久小说| 久久精品国产a三级三级三级| 爱豆传媒免费全集在线观看| 日韩一区二区视频免费看| 成人18禁高潮啪啪吃奶动态图 | 欧美高清性xxxxhd video| 高清日韩中文字幕在线| 久热这里只有精品99| 欧美一区二区亚洲| 亚洲经典国产精华液单| 国产老妇伦熟女老妇高清| 久久久午夜欧美精品| 蜜桃亚洲精品一区二区三区| 高清日韩中文字幕在线| 亚洲图色成人| 日韩伦理黄色片| 国产精品久久久久久精品古装| 肉色欧美久久久久久久蜜桃| 亚洲国产av新网站| 久久久久久伊人网av| 香蕉精品网在线| 国产精品福利在线免费观看| 一级黄片播放器| 高清黄色对白视频在线免费看 | 午夜老司机福利剧场| 免费大片黄手机在线观看| 丰满迷人的少妇在线观看| 80岁老熟妇乱子伦牲交| 国产男人的电影天堂91| av在线app专区| 免费播放大片免费观看视频在线观看| 久久久久性生活片| 男人舔奶头视频| 51国产日韩欧美| 国产永久视频网站| 简卡轻食公司| 两个人的视频大全免费| 国内精品宾馆在线| 全区人妻精品视频| 在线免费十八禁| 黄片无遮挡物在线观看| 国产日韩欧美亚洲二区| 欧美少妇被猛烈插入视频| 国产成人freesex在线| 最后的刺客免费高清国语| av网站免费在线观看视频| 欧美3d第一页| 日韩大片免费观看网站| 欧美变态另类bdsm刘玥| 少妇猛男粗大的猛烈进出视频| 午夜福利在线观看免费完整高清在| 国产成人aa在线观看| 亚洲成人中文字幕在线播放| 中文在线观看免费www的网站| 国国产精品蜜臀av免费| 欧美激情极品国产一区二区三区 | 午夜福利在线在线| 老熟女久久久| 欧美少妇被猛烈插入视频| 人妻制服诱惑在线中文字幕| 国产精品熟女久久久久浪| 一区二区三区精品91| 国产在线一区二区三区精| 精品久久国产蜜桃| 日韩,欧美,国产一区二区三区| 日本一二三区视频观看| 日本与韩国留学比较| 国产成人精品一,二区| 舔av片在线| 波野结衣二区三区在线| 日韩 亚洲 欧美在线| 精品人妻视频免费看| 国产亚洲av片在线观看秒播厂| 国产精品人妻久久久影院| 亚洲国产精品999| videossex国产| 中文字幕av成人在线电影| 亚洲精品国产av蜜桃| 午夜激情久久久久久久| 亚洲久久久国产精品| 美女cb高潮喷水在线观看| 亚洲av中文av极速乱| 欧美高清性xxxxhd video| 免费久久久久久久精品成人欧美视频 | 免费观看av网站的网址| 建设人人有责人人尽责人人享有的 | 国精品久久久久久国模美| 亚洲欧美一区二区三区黑人 | 国产精品.久久久| 亚洲国产色片| 久久精品久久久久久噜噜老黄| 联通29元200g的流量卡| 国产av国产精品国产| 1000部很黄的大片| 中文字幕制服av| 亚洲内射少妇av| 精品酒店卫生间| 下体分泌物呈黄色| 亚洲欧洲国产日韩| 国产午夜精品一二区理论片| 久久午夜福利片| 久久久午夜欧美精品| 尤物成人国产欧美一区二区三区| 我要看日韩黄色一级片| 高清午夜精品一区二区三区| 免费看av在线观看网站| 大码成人一级视频| 看免费成人av毛片| 乱系列少妇在线播放| 视频区图区小说| 国产av一区二区精品久久 | 亚洲性久久影院| 美女cb高潮喷水在线观看| 国产午夜精品久久久久久一区二区三区| 中文在线观看免费www的网站| 国产精品精品国产色婷婷| 全区人妻精品视频| 一级av片app| 国产一区亚洲一区在线观看| 日韩,欧美,国产一区二区三区| 中文乱码字字幕精品一区二区三区| 观看av在线不卡| 精品一品国产午夜福利视频| 国产精品久久久久久av不卡| 亚洲av中文av极速乱| 涩涩av久久男人的天堂| 在线观看美女被高潮喷水网站| 制服丝袜香蕉在线| 在线亚洲精品国产二区图片欧美 | 亚洲第一区二区三区不卡| 高清欧美精品videossex| 亚洲电影在线观看av| 一本一本综合久久| 国产免费福利视频在线观看| 国产乱来视频区| 汤姆久久久久久久影院中文字幕| 色视频www国产| 深夜a级毛片| 欧美高清性xxxxhd video| 亚洲国产av新网站| 中文在线观看免费www的网站| 各种免费的搞黄视频| av专区在线播放| 免费大片18禁| 成人免费观看视频高清| 国语对白做爰xxxⅹ性视频网站| 两个人的视频大全免费| 久久久久国产精品人妻一区二区| 免费观看a级毛片全部| 老熟女久久久| 国产成人免费观看mmmm| 国产成人精品一,二区| 精品一区在线观看国产| 国产伦理片在线播放av一区| 日韩成人av中文字幕在线观看| 欧美日本视频| 久久久久久久精品精品| 黄色日韩在线| 久久久色成人| 免费高清在线观看视频在线观看| 亚洲国产成人一精品久久久| 我的女老师完整版在线观看| 亚洲三级黄色毛片| 18禁在线播放成人免费| 一个人看的www免费观看视频| 在现免费观看毛片| 免费高清在线观看视频在线观看| 亚洲精品国产av蜜桃| 国产精品国产三级国产av玫瑰| 日韩一区二区视频免费看| 在线观看美女被高潮喷水网站| 久久女婷五月综合色啪小说| 亚洲精品日本国产第一区| 亚洲精品,欧美精品| 亚洲精品乱码久久久v下载方式| 自拍欧美九色日韩亚洲蝌蚪91 | 国产探花极品一区二区| 王馨瑶露胸无遮挡在线观看| 寂寞人妻少妇视频99o| 韩国高清视频一区二区三区| 九九久久精品国产亚洲av麻豆| 一级毛片aaaaaa免费看小| 黄色怎么调成土黄色| 高清午夜精品一区二区三区| 秋霞在线观看毛片| 国产一区亚洲一区在线观看|